When did Nature's Sunshine Products report Q1 2025 earnings?

Nature's Sunshine Products (NATR) reported Q1 2025 earnings on May 6, 2025 after market close.

What were Nature's Sunshine Products's Q1 2025 revenue and EPS?

Nature's Sunshine Products reported revenue of $113.2M and eps of $0.25 for Q1 2025.

Did Nature's Sunshine Products beat estimates in Q1 2025?

Revenue missed the consensus estimate of $114.4M by $1.2M. EPS beat the consensus estimate of $0.17 by $0.08.

How did Nature's Sunshine Products's Q1 2025 results compare year-over-year?

Compared to the same quarter a year prior, revenue grew 2.0% from $111.0M a year earlier and eps grew 108.3% from $0.12.

Where can I find Nature's Sunshine Products's Q1 2025 SEC filings?

You can read the 10-Q periodic report (0001628280-25-022765) directly on SEC EDGAR. The filing index links above go to sec.gov.

Nature's Sunshine Products NATR Q1 2025 earnings

Reported May 6, 2025 · After market close

Revenue$113.2MMiss by $1.2M

EPS$0.25Beat by $0.08

Revenue estimate$114.4M

EPS estimate$0.17

Next report

Aug 6, 2026 (In 1 week)

Revenue estimate$123.7M

EPS estimate$0.27

Financials

Q1 2025

Income statement

See full

Revenue$113.2M+2.0%

Gross profit$81.6M+3.3%

Operating income$6.2M+33.5%

Net income$4.7M+105%

EPS (diluted)$0.25+108%

Balance sheet

See full

Cash & equivalents$86.5M+11.2%

Total debt$14.8M-25.1%

Total equity$167.1M+4.6%

Total assets$252.7M+2.2%

Cash flow

See full

Operating cash flow$2.6M+19.1%

CapEx$1.1M-69.9%

Free cash flow$1.5M+200%

Valuation & ratios

Valuation

as of 03/31/25

See full

Market cap$231.97M-40.7%

Enterprise value$160.33M-51.9%

P/E22.2×-1.4×

P/S0.5×-0.4×

Profitability

See full

Gross margin71.7%-0.5pp

Operating margin4.7%-0.4pp

Net margin2.3%-1.4pp

FCF margin3.8%-1.2pp

Returns & leverage

See full

Return on equity6.4%-4.4pp

Debt / equity0.1×0.0×

Current ratio2.4×+0.1×

Segments

By product

See full

General health$45.9M+4.9%

Digestive$27.5M+4.2%

Cardiovascular$20.5M-1.7%

Immunity$10.3M+11.8%

Personal care$4.5M+3.2%

By segment

See full

Asia$48.7M+5.3%

North America$35.0M-4.1%

Europe$24.1M+8.2%

Latin America and Other$5.5M-8.2%

By geography

See full

United States$32.5M—

Taiwan$17.9M—

Japan$11.0M—

South Korea$10.8M—

Versus estimates

Revenue

Q1 2026$122.9MBeat by $742.0K Q4 2025$123.8MBeat by $2.3M Q3 2025$128.3MBeat by $6.7M Q2 2025$114.8MMiss by $4.6M

Q1 2025$113.2MMiss by $1.2M

Q4 2024$118.2MBeat by $8.9M

Diluted EPS

Q1 2026$0.30Beat by $0.10 Q4 2025$0.30Beat by $0.11 Q3 2025$0.36Beat by $0.17 Q2 2025$0.35Beat by $0.17

Q1 2025$0.25Beat by $0.08

Q4 2024-$0.02Miss by $0.22

Ask the moment Nature's Sunshine Products reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI

Claude

Questions, answered.

When did Nature's Sunshine Products report Q1 2025 earnings?: Nature's Sunshine Products (NATR) reported Q1 2025 earnings on May 6, 2025 after market close.
What were Nature's Sunshine Products's Q1 2025 revenue and EPS?: Nature's Sunshine Products reported revenue of $113.2M and eps of $0.25 for Q1 2025.
Did Nature's Sunshine Products beat estimates in Q1 2025?: Revenue missed the consensus estimate of $114.4M by $1.2M. EPS beat the consensus estimate of $0.17 by $0.08.
How did Nature's Sunshine Products's Q1 2025 results compare year-over-year?: Compared to the same quarter a year prior, revenue grew 2.0% from $111.0M a year earlier and eps grew 108.3% from $0.12.
Where can I find Nature's Sunshine Products's Q1 2025 SEC filings?: You can read the 10-Q periodic report (0001628280-25-022765) directly on SEC EDGAR. The filing index links above go to sec.gov.